Clinical effectiveness of second-line antihyperglycemic drugs on major adverse cardiovascular events: An emulation of a target trial
Introduction: The cardiovascular benefits of multiple antihyperglycemic drugs as add-on therapies to metformin in the real-practice are unclear. This study aimed to directly compare major adverse cardiovascular events (CVE) associated with these multiple drugs. Methods: An emulation of a target tria...
Saved in:
Main Author: | Siriyotha S. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/82448 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Effects of second-line antihyperglycemic drugs on the risk of chronic kidney disease: applying a target trial approach to a hospital-based cohort of Thai patients with type 2 diabetes
by: Siriyotha S.
Published: (2023) -
Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients
by: Thosaphol Limpijankit, et al.
Published: (2022) -
Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease.
by: Armstrong, E.J, et al.
Published: (2020) -
Antihyperglycemic activity of Ophiocordyceps sinensis: A Review
by: Kanjana Sirisidthi, et al.
Published: (2018) -
CYP2C19 phenotype in South?East Asian Acute Coronary Syndrome patients and impact on major adverse cardiovascular events
by: Tan DS, et al.
Published: (2020)